David Tepper
Appaloosa Management
David Tepper Aerie Pharmaceuticals Inc stake
total: 317
Appaloosa Management AERI trades
- Total transactions:
- 3
- New positions:
- 1
- Sold out:
- 1
- Reduced:
- 1
- Held since:
- 2017 Q2
- Held for:
- 2 quarters
- Latest activity:
- 2017 Q4
According to 2026 Q2 report, David Tepper doesn't hold any Aerie Pharmaceuticals Inc (AERI) shares. To date, the estimated cost basis is nearly $52.55 for "buy" trades and estimated average "sell" price is $48.6. Appaloosa Management first purchased AERI in 2017 Q2, initially acquiring 189,799 shares. Since the initial investment in Aerie Pharmaceuticals Inc (AERI), Appaloosa Management has made 2 more transactions.
When did David Tepper sell Aerie Pharmaceuticals Inc (AERI)?
David Tepper sold off the entire Aerie Pharmaceuticals Inc (AERI) position in 2017 Q4.
When did David Tepper buy Aerie Pharmaceuticals Inc (AERI)?
David Tepper first invested in Aerie Pharmaceuticals Inc (AERI) in 2017 Q2 at the reported quarter-end price of $52.55 per share.
What's the cost basis of Appaloosa Management's AERI stake?
The estimated cost basis for Aerie Pharmaceuticals Inc (AERI) stake is around $52.55 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $52.55
- Weighted AVG sell price:
- $48.60
David Tepper's historical trades in Aerie Pharmaceuticals Inc
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.